Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

BD buys infection surveillance firm

This article was originally published in Clinica

Executive Summary

BD Diagnostics has bolstered its portfolio of products designed to prevent and control infectious diseases by purchasing Austin, Texas-based ICPA, a specialist in infection surveillance systems. The acquisition provides BD with the AICE software system, which is designed to track and monitor emerging infection issues among patients and healthcare workers in hospitals. The software continuously tracks emerging drug-resistant organisms and the incidence of healthcare-associated infections, and generates alerts that signal critical risk of infections. BD provides a range of products for infection control, including rapid assays for detecting the presence of infectious organisms. Financial terms of the deal were not disclosed.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT044015

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel